NCT06445361Recruiting
Prevalence of NAFLD in T1DM Patients
The Prevalence of Non-Alcoholic Fatty Liver Disease in Type 1 Diabetes Mellitus Patients Followed at Ziekenhuis Oost-Limburg, Genk, Belgium
Source: ClinicalTrials.gov · Last updated 28 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To determine the prevalence of NAFLD in T1DM patients.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 138 (estimated)
- First submitted
- 28 Feb 2024
- Start date
- 1 Jul 2023
- Primary completion date
- 1 Jul 2026
- Lead sponsor
- Ziekenhuis Oost-Limburg
- NCT number
- NCT06445361
What you commit to
- Study type: Interventional
- Planned participants: 138
- From 1 Jul 2023 to the primary completion date, 1 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Exclusion of other causes of liver disease and secondary causes of liver steatosis
Other
- Excessive alcohol use
Who the study is looking for
- T1DM
- ≥ 18 years of age
- Written informed consent obtained
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ziekenhuis Oost-Limburg Coordinator of this site? Confirm its status | Genk | Belgium | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.